+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Hemochromatosis - Pipeline Review, H2 2019 - Product Thumbnail Image

Hemochromatosis - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 45 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1000 Pages
  • Global
From
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 631 Pages
  • Global
From
From
From
From
From
From
From
Drug Overview: Feraheme - Product Thumbnail Image

Drug Overview: Feraheme

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
From
Global Intravenous IV Solutions Market 2023-2027 - Product Thumbnail Image

Global Intravenous IV Solutions Market 2023-2027

  • Report
  • April 2023
  • 153 Pages
  • Global
From
Pruritus Therapeutics Global Market Report 2024 - Product Thumbnail Image

Pruritus Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator